13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inflammation has been linked to the pathophysiology of bipolar disorder based on studies of inflammation markers, such as cytokine concentrations, in plasma and serum samples from cases and controls. However, peripheral measurements of cytokines do not readily translate to immunological activity in the brain. The aim of the present study was to study brain immune and inflammatory activity. To this end, we analyzed cytokines in cerebrospinal fluid from 121 euthymic bipolar disorder patients and 71 age and sex matched control subjects. Concentrations of 11 different cytokines were determined using immunoassays. Cerebrospinal fluid IL-8 concentrations were significantly higher in patients as compared to controls. The other cytokines measured were only detectable in part of the sample. IL-8 concentrations were positively associated to lithium- and antipsychotic treatment. The findings might reflect immune aberrations in bipolar disorder, or be due to the effects of medication.

          Related collections

          Author and article information

          Journal
          Brain Behav. Immun.
          Brain, behavior, and immunity
          Elsevier BV
          1090-2139
          0889-1591
          Jan 2015
          : 43
          Affiliations
          [1 ] Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden. Electronic address: anniella.isgren@vgregion.se.
          [2 ] Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden.
          [3 ] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
          [4 ] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
          [5 ] Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
          [6 ] Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
          Article
          S0889-1591(14)00474-7
          10.1016/j.bbi.2014.10.001
          25451615
          24faf882-f5e5-4243-9cab-dd70d94481e3
          History

          Antipsychotic drugs,Biomarkers,Bipolar disorder,Cerebrospinal fluid,Cytokines,Interleukin-8,Lithium

          Comments

          Comment on this article